Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127572871 | 12757287 | 1 | I | 200703 | 20070406 | 20160919 | 20160919 | PER | US-ASTRAZENECA-2007BM00853 | ASTRAZENECA | 628.00 | MON | F | Y | 86.20000 | KG | 20160919 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127572871 | 12757287 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 26 | MG | U | 22200 | 2 | MG | /wk | |||||
| 127572871 | 12757287 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | U | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 127572871 | 12757287 | 3 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | U | A232255 | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||
| 127572871 | 12757287 | 4 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 127572871 | 12757287 | 5 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 127572871 | 12757287 | 6 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127572871 | 12757287 | 7 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127572871 | 12757287 | 8 | C | GLUCOVANCE | GLYBURIDEMETFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 2 | DF | QD | ||||||||
| 127572871 | 12757287 | 9 | C | GLUCOVANCE | GLYBURIDEMETFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | QD | ||||||||
| 127572871 | 12757287 | 10 | C | AVANDIA | ROSIGLITAZONE MALEATE | 1 | Oral | 0 | 8 | MG | QD | ||||||||
| 127572871 | 12757287 | 11 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Oral | 0 | 400 | IU | QD | ||||||||
| 127572871 | 12757287 | 12 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 127572871 | 12757287 | 13 | C | ALTACE | RAMIPRIL | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 127572871 | 12757287 | 14 | C | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | 0 | 1.25 | MG | QD | ||||||||
| 127572871 | 12757287 | 15 | C | DILTIAZEM. | DILTIAZEM | 1 | Oral | 0 | 240 | MG | QD | ||||||||
| 127572871 | 12757287 | 16 | C | MYOFLEX | TROLAMINE SALICYLATE | 1 | UNK | 0 | |||||||||||
| 127572871 | 12757287 | 17 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127572871 | 12757287 | 18 | C | WELCHOL | COLESEVELAM HYDROCHLORIDE | 1 | Oral | 0 | 3.75 | MG | QD | ||||||||
| 127572871 | 12757287 | 19 | C | INVOKANA | CANAGLIFLOZIN | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 127572871 | 12757287 | 20 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500.0MG UNKNOWN | 0 | 500 | MG | ||||||||
| 127572871 | 12757287 | 21 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 0 | 300 | MG | QD | ||||||||
| 127572871 | 12757287 | 22 | C | CARDIZEM | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 0 | 300 | MG | QD | ||||||||
| 127572871 | 12757287 | 23 | C | BENLAFAXINE | 2 | Oral | 75.0MG UNKNOWN | 0 | 75 | MG | |||||||||
| 127572871 | 12757287 | 24 | C | CLONOZAPAM | 2 | Oral | 0.5MG UNKNOWN | 0 | .5 | MG | |||||||||
| 127572871 | 12757287 | 25 | C | AMITIZA | LUBIPROSTONE | 1 | Oral | 24 UG/ML | 0 | ||||||||||
| 127572871 | 12757287 | 26 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | 0 | 1 | MG | QD | ||||||||
| 127572871 | 12757287 | 27 | C | PREVIDENT | SODIUM FLUORIDE | 1 | Oral | DAILY | 0 | ||||||||||
| 127572871 | 12757287 | 28 | C | RESTASIS | CYCLOSPORINE | 1 | Ophthalmic | 1 GIT | 0 | ||||||||||
| 127572871 | 12757287 | 29 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Oral | 0 | |||||||||||
| 127572871 | 12757287 | 30 | C | METAMUCIL | PLANTAGO SEED | 1 | Oral | DAILY | 0 | ||||||||||
| 127572871 | 12757287 | 31 | C | MULTIVITAMIN | VITAMINS | 1 | Oral | DAILY | 0 | ||||||||||
| 127572871 | 12757287 | 32 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | 600.0MG UNKNOWN | 0 | 600 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127572871 | 12757287 | 1 | Type 2 diabetes mellitus |
| 127572871 | 12757287 | 2 | Type 2 diabetes mellitus |
| 127572871 | 12757287 | 3 | Type 2 diabetes mellitus |
| 127572871 | 12757287 | 4 | Anxiety |
| 127572871 | 12757287 | 5 | Depression |
| 127572871 | 12757287 | 6 | Anxiety |
| 127572871 | 12757287 | 7 | Depression |
| 127572871 | 12757287 | 10 | Diabetes mellitus |
| 127572871 | 12757287 | 11 | Ill-defined disorder |
| 127572871 | 12757287 | 12 | Blood cholesterol |
| 127572871 | 12757287 | 13 | Blood pressure increased |
| 127572871 | 12757287 | 14 | Blood pressure increased |
| 127572871 | 12757287 | 17 | Blood cholesterol increased |
| 127572871 | 12757287 | 18 | Blood cholesterol increased |
| 127572871 | 12757287 | 19 | Blood glucose abnormal |
| 127572871 | 12757287 | 20 | Blood glucose abnormal |
| 127572871 | 12757287 | 21 | Blood glucose abnormal |
| 127572871 | 12757287 | 22 | Hypertension |
| 127572871 | 12757287 | 23 | Depression |
| 127572871 | 12757287 | 24 | Anxiety |
| 127572871 | 12757287 | 25 | Abnormal faeces |
| 127572871 | 12757287 | 26 | Blood glucose abnormal |
| 127572871 | 12757287 | 28 | Dry eye |
| 127572871 | 12757287 | 29 | Limb discomfort |
| 127572871 | 12757287 | 30 | Abdominal discomfort |
| 127572871 | 12757287 | 32 | Bone disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127572871 | 12757287 | Arthralgia | |
| 127572871 | 12757287 | Back pain | |
| 127572871 | 12757287 | Dizziness | |
| 127572871 | 12757287 | Gastrointestinal pain | |
| 127572871 | 12757287 | Injection site mass | |
| 127572871 | 12757287 | Injection site pain | |
| 127572871 | 12757287 | Pharyngitis bacterial | |
| 127572871 | 12757287 | Tooth injury | |
| 127572871 | 12757287 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127572871 | 12757287 | 1 | 20160203 | 0 | ||
| 127572871 | 12757287 | 2 | 200610 | 2006 | 0 | |
| 127572871 | 12757287 | 3 | 2006 | 0 | ||
| 127572871 | 12757287 | 16 | 20070427 | 0 | ||
| 127572871 | 12757287 | 27 | 20160428 | 0 |